Thursday, May 24, 2018

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. Aimovig blocks a protein fragment, CGRP, that instigates and perpetuates migraines

from Health https://ift.tt/2KQP9Eq

Related Posts:

  • LATEST HEALTH NEWSA U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Ind… Read More
  • LATEST HEALTH NEWSChina's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua sa… Read More
  • LATEST HEALTH NEWSThe Iowa and Illinois health departments said on Thursday that they were investigating cyclospora infections linked to salads at McDonald Corp's restaurants. from Reuters: Health News https://ift.tt/2mblWcS … Read More
  • LATEST HEALTH NEWSScientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells. from Reuters: Health N… Read More
  • LATEST HEALTH NEWSIndivior Plc's shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker's bestselling opioid addiction treatment. from Reuters: Health News h… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner